• Goldman Sachs GS has invested $450.0 million in social networking firm Facebook, and is planning to invest another $1.5 billion, making the value of the site at about $50 billion
• Bank of America BAC has reported fourth quarter charges of $3 billion on its GSE exposure, and $2 billion in its insurance unit
• Johnson & Johnson JNJ and Boston scientists are planning jointly to bring blood testing of cancer cells to the market
• Barrons has recommended ten big-cap companies which includes the names of Exxon Mobil, XOM, Wal-Mart WMT, Pfizer PFE, JP Morgan JPM, General Motors GM, and Cisco CSCO
• Alcoa AA received a Deutsche Bank DB upgrade to "buy" rating from "hold," with a target price of $22 from $14.
• Boeing BA was upgraded by JP Morgan JPM to "overweight," from "neutral" rating
• Barclays BCS has maintained their "overweight" ranking, but has lowered the target price from $87 to $80
• Amazon.com AMZN was rated at "overweight" by Morgan Stanley MS, with revenues expected to increase 194% to $100 billion by 2015
• General Motors GM was added as a new "buy" by Goldman Sachs GS with a target price of $43
• Piper Jaffray PJC downgraded shares of Intel INTC from "overweight" to "neutral," with a target price of $21.50
• Citigroup C added Advanced Micro Devices AMD to its Top Picks List
• Teradyne TER shares were removed from Goldman Sachs' Conviction Buy List, but remained at a "buy" rating
ALCOA INC (AA): Free Stock Analysis Report
AMAZON.COM INC (AMZN): Free Stock Analysis Report
BOEING CO (BA): Free Stock Analysis Report
BANK OF AMER CP (BAC): Free Stock Analysis Report
BARCLAY PLC-ADR (BCS): Free Stock Analysis Report
DEUTSCHE BK AG (DB): Free Stock Analysis Report
GOLDMAN SACHS (GS): Free Stock Analysis Report
INTEL CORP (INTC): Free Stock Analysis Report
JOHNSON & JOHNS (JNJ): Free Stock Analysis Report
JPMORGAN CHASE (JPM): Free Stock Analysis Report
MORGAN STANLEY (MS): Free Stock Analysis Report
PFIZER INC (PFE): Free Stock Analysis Report
PIPER JAFFRAY (PJC): Free Stock Analysis Report
EXXON MOBIL CRP (XOM): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.